Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
£1.5million funding boost to help unlock the genetic secrets of aggressive neuroblastoma
Scientists from The Institute of Cancer Research, London, will be part of a team of international researchers who have secured funding to study the genetic secrets of childhood cancer neuroblastoma.
.jpg?sfvrsn=999b1809_2 "Clinical trials pills bottles (16.9)")
Genetic factors likely to determine which patients will benefit from new prostate cancer combination therapy
Researchers have uncovered several biological signs that may determine how metastatic castration-resistant prostate cancer (mCRPC) responds to a new treatment combination.
Scientists develop new tool to beat cancer’s survival tactics
Scientists have developed a tool which helps them better understand cancer’s survival tactics – and could eventually lead to new treatments for dozens of cancer types.
New research might make an ‘undruggable’ target druggable – leading to new cancer drugs
Drug discovery researchers have made significant progress towards targeting a protein that is seen as a promising anticancer target but has, until now, been considered undruggable.
New AI model effectively predicts patient outcomes in a common type of lung cancer
Researchers have developed an artificial intelligence-based model that can help pathologists grade certain lung cancer tumours and predict patients’ outcomes.
Blood cancer patients should be offered genetic testing to spot ‘double hit’ high-risk cases earlier
Offering extended genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, say scientists from The Institute of Cancer Research, London.
Simple blood test could lead to smarter, kinder treatments for childhood cancers
Institute of Cancer Research scientists have developed a simple blood test that will help them better understand children’s cancers - and pave the way for new targeted and less toxic treatments.
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body – identifying ways to block its escape
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.
New data tool could bring RNA sequencing into standard clinical practice, improving diagnosis and treatment
Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions.
Breast cancer risk model provides reassuring data for those with family history of disease after short-term HRT use
Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk model published in the British Journal of General Practice.
Scientists create new way to predict bowel cancer risk in people with inflammatory bowel disease
Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer.
Genetic testing for Lynch Syndrome prevents cancers being missed
Genetic testing to identify women with Lynch Syndrome is likely to need to increase dramatically to ensure that carriers are not missed, a new analysis by ICR researchers has found.